Andrew M. Arsham
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology top 10%
- Epidemiology
- Physiology top 10%
- Co-authors
- M. Celeste SimonJessica J. HowellBrian KeithThomas P. NeufeldCheng‐Jun HuPatricia A. LaboskyKelly L. CovelloJames Kehler
- Topics
- Cancer, Hypoxia, and Metabolism (8 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)Mitochondrial Function and Pathology (3 papers)
- Partner nations
- United StatesSlovakiaFrance
In The Last Decade
Andrew M. Arsham
13 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Molecular Biology 1.3k
- Cancer Research 999
- Oncology 319
- Epidemiology 248
- Physiology 207
Countries citing papers authored by Andrew M. Arsham
This map shows the geographic impact of Andrew M. Arsham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Arsham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Arsham more than expected).
Fields of papers citing papers by Andrew M. Arsham
This network shows the impact of papers produced by Andrew M. Arsham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Arsham. The network helps show where Andrew M. Arsham may publish in the future.
Co-authorship network of co-authors of Andrew M. Arsham
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Arsham. A scholar is included among the top collaborators of Andrew M. Arsham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Arsham. Andrew M. Arsham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 67 | |
| 5 | 140 | |
| 6 | 48 | |
| 7 | HIF-2α regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growthbreakdown → | 657 |
| 8 | 101 | |
| 9 | 99 | |
| 10 | 78 | |
| 11 | 137 | |
| 12 | 384 | |
| 13 | 1 | |
| 14 | 147 | |
| 15 | 77 |
About Andrew M. Arsham
Andrew M. Arsham is a scholar working on Cancer Research, Molecular Biology and Hepatology, having authored 15 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (8 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Cancer Research (999 citations), Aging (42 citations) and Molecular Biology (1.3k citations). Andrew M. Arsham has collaborated with scholars based in United States, Slovakia and France. Frequent co-authors include M. Celeste Simon, Jessica J. Howell, Brian Keith, Thomas P. Neufeld, Cheng‐Jun Hu, Patricia A. Labosky, Kelly L. Covello, James Kehler, Hongwei D. Yu and John D. Gordan. Their work appears in journals such as Journal of Biological Chemistry, Genes & Development and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.